Skip to main content

Table 4 The discriminative validity of the Evidence-Based Medicine Questionnaire

From: Development and validation of the Evidence Based Medicine Questionnaire (EBMQ) to assess doctors’ knowledge, practice and barriers regarding the implementation of evidence-based medicine in primary care

Item

Details of item

With EBM training (n = 222) n(%)

Without EBM training (n = 98) n(%)

Chi-square

p-value

Unaware

Aware but not used in clinical decision making

Have read it but not used in clinical decision making

Read and used in clinical decision making

Unaware

Aware but not used in clinical decision making

Have read it but not used in clinical decision making

Read and used in clinical decision making

Knowledge Domain (Information sources related to EBM)

 C2

Bandolier

154(69.4)

35(15.8)

19(8.6)

14(6.3)

66(67.3)

13(13.3)

12(12.2)

7(7.1)

1.350

0.717

 C5

DARE

155(18.9)

42(18.9)

16(7.2)

9(4.1)

71(72.4)

15(15.3)

12(12.2)

6.510

0.089

 C6

CEBM

123(56.3)

69(31.1)

17(7.7)

11(5.0)

58(59.2)

22(22.4)

14(14.3)

4(4.1)

5.074

0.166

 C10

ACP

147(66.2)

38(17.1)

24(10.8)

13(5.9)

63(64.3)

16(16.3)

14(14.3)

5(5.1)

0.825

0.844

 C13

InfoClinics

152(68.5)

44(19.8)

18(8.1)

8(3.6)

63(64.3)

16(16.3)

10(10.2)

9(9.2)

4.946

0.176

 C14

CRD

175(78.8)

31(14.0)

15(6.8)

1(0.5)

75(76.5)

12(12.2)

9(9.2)

2(2.0)

2.564

0.464

 C3

EBM

10(4.5)

46(20.7)

66(29.7)

100(45.0)

4(4.1)

28(28.6)

24(24.5)

42(42.9)

2.577

0.462

 C12

BMJ

26(11.7)

43(19.4)

73(32.9)

80(36.0)

10(10.2)

25(25.5)

22(22.4)

41(41.8)

4.442

0.218

Item

Details of item

With EBM training

(n = 222) n(%)

Without EBM training

(n = 98) n(%)

Chi-square

p-value

Never heard and do not understand

Do not understand but would like to

Understand

Never heard and do not understand

Do not understand but would like to

Understand

Knowledge Domain (Terms related to EBM)

 K1

Systematic review

6(2.7)

12(5.4)

204(91.9)

8(8.2)

8(8.2)

82(83.7)

5.975

0.050

 K2

Meta-analysis

10(4.5)

14(6.3)

198(89.2)

6(6.1)

14(6.3)

198(89.2)

16.837

≤ 0.001*

 K3

Case-control study

4(1.8)

8(3.6)

210(94.6)

5(5.1)

8(3.1)

90(91.8)

2.746

0.253

 K4

Randomized controlled trial

4(1.8)

7(3.2)

211(95.0)

4(4.1)

1(1.0)

93(94.9)

2.651

0.266

 K5

Relative risk

8(3.6)

25(11.3)

189(85.1)

9(9.2)

16(16.3)

73(74.5)

6.287

0.043*

 K6

Absolute risk

8(3.6)

33(14.9)

181(81.5)

10(10.2)

15(15.3)

73(74.5)

5.699

0.058*

 K7

Odds ratio

11(0.5)

60(27.0)

151(68.0)

14(14.3)

26(26.5)

58(59.2)

8.395

0.015*

 K8

P-value

11(5.0)

38(17.1)

173(77.9)

14(14.3)

19(19.4)

65(66.3)

9.004

0.011*

 K9

Level of evidence

7(3.2)

30(13.5)

185(83.3)

9(9.2)

19(19.4)

70(71.4)

7.686

0.021*

 K10

Number needed to treat

11(5.0)

42(18.5)

170(76.6)

11(11.2)

20(20.4)

67(68.4)

4.640

0.098*

 K11

Confidence interval

17(7.7)

61(27.5)

144(64.9)

21(21.4)

25(25.5)

52(53.1)

12.502

0.002*

 K12

Heterogeneity

21(9.5)

74(33.3)

127(57.2)

22(22.4)

35(35.7)

41(41.8)

11.709

0.003*

 K13

Publication bias

23(10.4)

65(29.3)

134(60.4)

23(23.5)

30(30.6)

45(45.9)

10.703

0.005*

 K14

Test sensitivity and specificity

4(1.8)

25(11.3)

193(86.9)

11(11.2)

13(13.3)

74(75.5)

14.172

≤ 0.001*

 K15

Positive predictive value

5(2.3)

36(16.2)

181(81.5)

5(2.3)

36(16.2)

181(81.5)

7.415

0.025*

 K16

Clinical effectiveness

10(4.5)

48(21.6)

164(73.9)

16(16.3)

19(19.4)

63(64.3)

12.738

0.002*

Item

Details of item

With EBM training

(n = 222) n(%)

Without EBM training

(n = 98) n(%)

Chi-square

p-value

Disagree

Neutral

Agree

Disagree

Neutral

Agree

Practice Domain

 P1

I support EBM

1(0.5)

8(3.6)

213(95.9)

2(2.0)

6(6.1)

90(91.8)

2.941

0.230

 P2

I trust the findings from research studies

1(0.5)

37(16.7)

184(82.9)

3(3.1)

13(13.3)

82(83.7)

4.216

0.121

 P3

Reading research papers is important to me

25(11.3)

197(88.7)

4(4.1)

20(20.4)

74(75.5)

14.511

0.001*

 P4

EBM improves my patient care

19(8.6)

203(91.4)

3(3.1)

8(8.2)

87(88.8)

6.862

0.032*

 P5

EBM reduces my workload

22(9.9)

87(39.1)

113(50.9)

21(9.4)

39(17.5)

38(17.1)

8.838

0.012*

 P6

I can implement EBM in my clinical practice

2(0.9)

23(10.3)

197(88.7)

3(1.3)

16(7.2)

79(35.5)

4.537

0.103

 P7

EBM guides my clinical decision making

11(5.0)

211(95.0)

3(3.1)

9(9.2)

86(87.8)

9.130

0.010*

 P8

I prefer to manage patients based on EBM

2(0.9)

36(16.2)

184(82.9)

3(3.1)

25(25.5)

70(71.4)

6.235

0.044*

Barriers Domain

 B1

I am able to assess the quality of research.

35(15.8)

76(34.2)

111(50.0)

17(17.3)

40(40.8)

41(41.8)

1.871

0.392

 B2

I have access to internet to practice EBM

4(1.8)

18(8.1)

200(90.1)

11(11.2)

12(12.2)

75(76.5)

15.573

< 0.001*

 B3

I have time to read research papers

25(11.3)

93(41.9)

104(46.8)

22(22.4)

39(39.8)

37(37.8)

7.142

0.028*

 B4

I have time to practise EBM in my clinic

18(8.1)

60(27.0)

144(64.9)

144(64.9)

17(17.3)

32(32.7)

8.545

0.014*

 B5

My clinic facilities are adequate to support the practice of EBM

47(20.2)

85(38.2)

90(40.5)

34(15.3)

34(15.3)

120(54.0)

6.935

0.031*

 B6

Research articles are easily available to me

50(22.5)

71(32.0)

101(45.5)

40(40.8)

29(29.6)

29(29.6)

12.447

0.002*

 B8

My patients prefers me to practise EBM

28(12.6)

138(62.2)

56(25.2)

15(15.3)

59(60.2)

24(24.5)

0.424

0.809

 B9

My patient believes in information that is based on evidence

35(15.8)

95(42.8)

92(41.4)

11(11.2)

47(48.0)

40(40.8)

1.391

0.499

 B12

My colleagues support the practice of EBM

13(5.9)

84(37.8)

125(56.3)

12(12.2)

36(36.7)

50(51.0)

3.922

1.141

 B13

My organization supports the practice of EBM

12(5.4)

72(32.4)

138(62.2)

8(8.2)

33(33.7)

57(58.2)

1.038

0.595

  1. EBM Evidence-based medicine
  2. *p ≤ 0.05 is significant